Drug stocks over, Noida hospital gasps for breath | india | Hindustan Times
Today in New Delhi, India
Aug 17, 2017-Thursday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Drug stocks over, Noida hospital gasps for breath

The sole government hospital in Noida is running short of many vital life-saving drugs.

india Updated: May 01, 2012 01:39 IST
Astha Saxena

The sole government hospital in Noida is running short of many vital life-saving drugs.

“We don’t have many life-saving drugs in the hospital. Left with no solution, we have to refer patients to other hospitals,” said a doctor. The district hospital which was shifted few months back from sector 39 to sector 30, where a multi-crore government helath facility is coming up.

The fate of this super-speciality hospital also hangs in the balance as the state government has failed to appoint a new CEO at theNoida authority. The CEO has take to make several decisions regarding the hospital.

At the currently functional hospital, many medicines such as Betadine, life-saving drugs, pain killers, ORS and many more are not available. According to officials, admission has also declined by 20-25per cent as compared to the last year figures.

More than 1,000 patients daily come to the hospital, which is a dream project of former chief minister of UP Mayawati.

“Even the patients who are already admitted in the hospital are leaving as the required medicines are not available in the hospital. We can’t stop them as their health is more important,” said the doctor.

However, the officials have a different opinion when they talk on record. “The hospital is equipped with all the required medicines and drugs. No patient is being turned down due to any shortage,” said Dr Meena Mishra, chief medical superintendent of the hospital.

Last month, 125 cleaning staff, 14 doctors and 53 nursing staff stopped reporting at the hospital as their contract ended and it was not extended. The Noida authority chief executive officer who takes care of the hospital was transferred six weeks ago and no new CEO has so far joined in.